Alternative variants of human HYDIN are novel cancer-associated antigens recognized by adaptive immunity. - Laske K; Shebzukhov YV; Grosse-Hovest L; Kuprash DV; Khlgatian SV; Koroleva EP; Sazykin AY; Penkov DN; Belousov PV; Stevanovic S; Vass V; Walter S; et al. (Cancer immunology research, 2013)